Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasunobu Miyake, Kenichi Asano, Hitomi Kaise, Miho Uemura, Manabu Nakayama, Masato Tanaka
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2268–2278 doi:10.1172/JCI31990
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Delay of apoptotic cell clearance in DT-treated CD169-DTR mice.

We intraperitoneally injected 10 μg/kg of DT into wild-type (+/+) or CD169-DTR (+/CD169DTR) mice. Four days after DT treatment, CMFDA-labeled (green) apoptotic W3/MOG-L cells (2 × 107 cells) were intravenously injected, and the spleen was obtained at the indicated times after injection. (A) Cryosections of the spleens were stained with F4/80 (red pulp macrophage), ER-TR9 (MZM), CD169 (MMM), CD11c (DC), or MAdCAM-1 (marginal sinus-lining cell) (red). (B) Fluorescence intensity in MZ on the slices was quantified at the indicated time points, and mean values are shown with SEM. These results are representative of 2 independent experiments. Original magnification, ×200.